Pulmosal by is a Other medication manufactured, distributed, or labeled by PharmaCaribe. Drug facts, warnings, and ingredients follow.
Pulmosal 7% (pH+) 4 mL
Sodium Chloride Inhalation Solution 7%,
Sterile, Preservative-free, Non-pyrogenic, pH 7.4
Each Single-use vial contains 4ml sterile, preservative-free, non-pyrogenic Sodium Chloride Solution 7% for inhalation, pH 7.4
FOR INHALATION ONLY
NOT FOR INJECTION.
Patent Pending
RX Only
60 x 4 mL Unit-Dose Vial
NOT SUBSTITUTABLE with USP 7% Sodium Chloride
PULMOSAL
nebulizer (direct patient interface) |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - PharmaCaribe (011702541) |
Registrant - PharmaCaribe (011702541) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
PharmaCaribe | 011702541 | label |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PULMOSAL 85682088 4308546 Live/Registered |
Pharmacaribe 2012-07-19 |